Krebs Biochemicals & Industries Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a revenue from operations of Rs. 680.91 lacs for the quarter, compared to Rs. 727.42 lacs in the previous quarter (a decrease of 6.40%) and Rs. 610.05 lacs in the corresponding quarter of the previous year (an increase of 11.62%). The profit/loss before tax for the quarter was a loss of Rs. 233.96 lacs, compared to a loss of Rs. 312.65 lacs in the previous quarter and a loss of Rs. 825.31 lacs in the corresponding quarter of the previous year.

Krebs Biochemicals & Industries Limited is a company engaged in the biotechnology and chemical industry, focusing on manufacturing and supplying various biochemical products. The company’s operations are centered around its manufacturing unit in Vizag, which has faced closure following an order from the Andhra Pradesh Pollution Control Board on February 7, 2025. The company is currently engaged in active dialogue with the Pollution Control Board to secure the revocation of this closure order.